| Apoptotic cell signaling in cancer progression and therapy J Plati, O Bucur, R Khosravi-Far Integrative Biology 3 (4), 279-296, 2011 | 373 | 2011 |
| Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities J Plati, O Bucur, R KhosraviFar Journal of cellular biochemistry 104 (4), 1124-1149, 2008 | 260 | 2008 |
| Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy Y Zhao, O Bucur, H Irshad, F Chen, A Weins, AL Stancu, EY Oh, ... Nature biotechnology 35 (8), 757, 2017 | 210 | 2017 |
| Crowdsourcing Image Annotation for Nucleus Detection and Segmentationin Computational Pathology: Evaluating Experts, Automated Methods, and the Crowd H Irshad, L Montaser-Kouhsari, G Waltz, O Bucur, NC Jones, F Dong, ... Pacific Symposium on Biocomputing (PSB), 2015 | 162 | 2015 |
| Apoptotic pathways in tumor progression and therapy A Melet, K Song, O Bucur, Z Jagani, AR Grassian, R Khosravi-Far Programmed cell death in cancer progression and therapy, 47-79, 2008 | 144* | 2008 |
| Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT A Singh, M Ye, O Bucur, S Zhu, MT Santos, I Rabinovitz, W Wei, D Gao, ... Molecular Biology of the Cell 21 (6), 1140-1152, 2010 | 136 | 2010 |
| Sensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor S Ray, O Bucur, A Almasan Apoptosis 10 (6), 1411-1418, 2005 | 91 | 2005 |
| APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy O Bucur, S Ray, MC Bucur, A Almasan Front Biosci 11, 1549-1568, 2006 | 74 | 2006 |
| A peroxidase peroxiredoxin 1-specific redox regulation of the novel FOXO3 microRNA target let-7 BL Hopkins, M Nadler, JJ Skoko, T Bertomeu, A Pelosi, PM Shafaei, ... Antioxidants & redox signaling 28 (1), 62-77, 2018 | 63 | 2018 |
| Extensive rewiring of epithelial-stromal co-expression networks in breast cancer EY Oh, SM Christensen, S Ghanta, JC Jeong, O Bucur, B Glass, ... Genome biology 16 (1), 128, 2015 | 59 | 2015 |
| Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways V Gunda, O Bucur, J Varnau, PV Borre, MJ Bernasconi, R Khosravi-Far, ... Cell death & disease 5 (3), e1104, 2014 | 50 | 2014 |
| Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. MK Bhasin, K Ndebele, O Bucur, EU Yee, HH Otu, J Plati, A Bullock, X Gu, ... Oncotarget, 2016 | 45 | 2016 |
| Nanoscale imaging of clinical specimens using conventional and rapid-expansion pathology O Bucur, F Fu, M Calderon, GH Mylvaganam, NL Ly, J Day, S Watkin, ... Nature Protocols, 1-24, 2020 | 35 | 2020 |
| A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death O Bucur, G Gaidos, A Yatawara, B Pennarun, C Rupasinghe, J Roux, ... Scientific Reports 5, e9893, 2015 | 29 | 2015 |
| Combination of bortezomib and mitotic inhibitors down-modulate bcr-abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant bcr-abl-positive leukemic cells O Bucur, AL Stancu, I Goganau, SM Petrescu, B Pennarun, T Bertomeu, ... PloS one 8 (10), e77390, 2013 | 27 | 2013 |
| PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor O Bucur, AL Stancu, MS Muraru, A Melet, SM Petrescu, R Khosravi-Far Discoveries 2 (2), e15, 2014 | 25 | 2014 |
| Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications O Bucur, AL Stancu, R Khosravi-Far, A Almasan Cell death & disease 3 (2), e263, 2012 | 19 | 2012 |
| Thyroid-related adverse events induced by immune checkpoint inhibitors A Chera, AL Stancu, O Bucur Frontiers in Endocrinology, 2277, 2022 | 18 | 2022 |
| Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP O Bucur, B Pennarun, AL Stancu, M Nadler, MS Muraru, T Bertomeu, ... Apoptosis 18 (10), 1154-1162, 2013 | 17 | 2013 |
| killerFLIP: a novel lytic peptide specifically inducing cancer cell death B Pennarun, G Gaidos, O Bucur, A Tinari, C Rupasinghe, T Jin, R Dewar, ... Cell death & disease 4 (10), e894, 2013 | 15 | 2013 |
Andrew H. BeckCo-Founder and CEO at PathAI在 PathAI.com 的电子邮件经过验证
